17-alpha-estradiol dosage and evidence
Written by Aaron CuhaReviewed Sep 2026
The short answer
In male mice, it has made them live longer again and again, even at higher doses and even when started late in life. It does nothing for female mice, and nobody knows why.
Evidence grade for 17-alpha-estradiol: Animal or lab only. The rule: only animal or lab studies on this page. No study in people yet. The sum on this page: 4 animal studies, no human study. A grade counts how much has been done to people, not whether it works.
- People given it
- 0
- Human studies
- 0
- Found nothing
- 0
Dose
No human dose established
No published study on this page has given this compound to people and reported a result.
4 animal studies, no human study
4 effects reported, 3 unwanted, 1 wanted, by people using it, not a trial
Goal pages: Ageing and longevity, Injury, healing and recovery, Hormones and growth hormone, Immune system and inflammation, Gut health
In plain English
In plain English, from Aaron
This is how I would explain it to a friend. The evidence, with the numbers, is further down the page.
This is a mirror image form of the main female hormone. The flip makes it very weak at the usual hormone switches. So it does not feminise a male animal. Mice fed it lived longer. Only the males did.
What people take it for
- Living longer, because the mouse result is one of the strongest there is.
- Better blood sugar handling in the liver.
- Hair loss, in Europe, where a scalp version is sold. That is a different use.
What studies in people showed
Nobody has tested this in people for ageing. Not one study. Since nobody can patent it, nobody is likely to pay for one. In mice, the US government testing program found male mice lived longer. At three times the first dose, the longest lived males lived longer too. Another round found it still worked when started late in life. Almost nothing else can say that. In female mice it did nothing at all. Not less. Nothing.
What people report
Reports, not study results
The good
- We have not collected user reports on this one yet.
- There is no product for the whole body to buy, so there is nothing to report on.
The bad
- Nobody knows what it does in a person. No safety data exists at all.
- It did nothing for female mice, and nobody can explain why.
- The scalp product sold for hair loss is a different dose and a different route. It tells you nothing about this.
Where these come from: The mouse studies on this page. There are no user reports and no human studies to draw from, so nothing above comes from a person.
My bottom line
A strong mouse result in half the mice, with no idea why, and nothing in people. I would not take it. I would watch it.
An opinion, not a finding. I am a coach, not a doctor.
What it has been measured to do
Animal and lab work, not yet tested in people
Real results, but from animals or cells, not people. What works in a mouse often does not work the same way in a person. Nobody can patent this, so nobody would ever earn back the cost of a study in people. That is usually why there is none. The record on this one is set out below.
- Living longer2 animal or lab studies
- Testosterone and male hormones1 animal or lab study
- Inflammation1 animal or lab study
33 of the 36 indexed goals have no study of any kind behind 17-alpha-estradiol
No study in people, animals or cells on this page reports a result for these. That does not prove 17-alpha-estradiol does nothing for them. It does mean anything you have heard about 17-alpha-estradiol and one of these did not come from a study cited here.
Show full evidence
What is 17-alpha-estradiol?
In male mice, it has made them live longer again and again, even at higher doses and even when started late in life. It does nothing for female mice, and nobody knows why.
This is one of the strongest drug results for lifespan anywhere. It comes with a catch so big that most coverage leaves it out.
17-alpha-estradiol is a mirror-image form of the main female hormone, estrogen. Because of its shape, it barely switches on the body's usual estrogen receptors. So it does not have the feminising effects of normal estrogen. That is why it can be given to male animals at all.
Nobody has tested it for ageing in people.
In mice, the US government testing program found it made them live longer, more than once. At three times the earlier dose, it raised both the typical lifespan and how long the longest-lived mice got. A separate round found it still worked when started late in life. Almost no lifespan treatment can claim that.
In every one of those tests, only the males benefited. Not less in females. None at all.
How does 17-alpha-estradiol work?
It is the mirror-image form of normal estradiol. That small flip makes it far weaker at the usual estrogen receptors, so it loses the feminising effects. Because it is not acting like a normal estrogen, nobody knows how it makes mice live longer. Reported effects in mice include less inflammation in the hypothalamus, a brain area that runs hunger and hormones. They also include a better insulin response in the liver, less mTOR growth signalling in the liver, and better metabolic health markers. The male-only result is the heart of the puzzle. If it worked through a route that has nothing to do with hormones, there is no clear reason it would fail in females. But it does fail in females.
What have studies in people found about 17-alpha-estradiol?
None for ageing. No study in people has looked at lifespan, healthy years or any ageing measure with this compound.
- We found no study in people of 17-alpha-estradiol for ageing, healthy years or metabolic health.
- Some European countries sell it as a scalp treatment for pattern hair loss. That is a different use, a different dose and a different way into the body.
- All the lifespan results are in mice that ate it in their food every day.
What this does not tell you: The whole case is a mouse result, and it only works in males. To try this in people, you would need to know how it works. Nobody does. The hair loss use on the scalp tells you nothing about what happens when the whole body gets a lifespan-sized dose.
The state of the research
Here is the part most coverage skips. Several of this program's most reliable wins made male mice live longer and did nothing for female mice. This is not a case of too few mice. The female results simply do not move. Nobody knows why. Guesses include that males and females break the drug down differently, that they die of different things, or that their hormones differ. In practice, when a headline says a compound makes mice live longer, it often means half the mice. It usually does not say which half.
The Interventions Testing Program is the US government's mouse testing program, run by the National Institute on Aging. It runs every test at three separate labs at once. It uses mice bred to be genetically mixed, so a result cannot come from one odd strain. It tests males and females. Its groups are big enough to spot about a 10 percent change in lifespan. It publishes its failures next to its wins. Nothing else in ageing research does all of that. So its results count for more than one lab's result. And when it fails to repeat a result, that matters just as much as a win.
The evidence, in charts
Fig. 1a · how many people
0people have taken this in any study cited here
0 people · 0 studies in people
What this page cites instead is 4 animal studies. None of them gave the compound to a person.
Counted from the list of sources on this page. We draw this chart only when a study in people is cited. An empty one is the answer, not a gap in the page.
Fig. 1b · evidence mix
None of the 4 sources here are studies in people.
- Animal study · done in animals4100%
Counted from the list of sources on this page. It counts only what we cite, so there may be more studies out there. A review counts once, however many studies it sums up.
Fig. 2 · evidence over time
The studies cover 4 different years, 2014 to 2021, counted from the list of sources on this page.
Fig. 3 · legal status at a glance
US
Not approved
UK
Not approved
AU
Not approved
CA
Not approved
Not approved in any of the four countries shown. This is what the law says, not a verdict on the science. See Legal status below for the full text and any notes.
Fig. 4 · how much does what
Nobody has tested different amounts in people
This chart would show how the effect changes as the amount goes up. For this compound, nobody has measured that in people. So we leave it empty. We will not borrow an animal chart and pretend it works the same in people.
Fig. 5 · what the molecule is
- Kind of compound
- Hormone
- Molecule weight
- 272.4 Da. A steroid, not a peptide.
- Half-life
- Stated in words, not a numbersee the exact wording below
- Chain length
- None on file
Half-life as stated on file: Not asserted for the mouse dosing regimen. It is fed in the diet in these studies, so exposure is continuous rather than pulsed.
No amino acid sequence is on file for 17-alpha-estradiol, which is expected: a hormone is not built from amino acids.
The studies we cite
- Animal study2016Longer lifespan in male mice treated with a weakly estrogenic agonist, an antioxidant, an alpha-glucosidase inhibitor or a Nrf2-inducer
In mice, a higher dose worked even better, but still only in males. At three times the earlier dose, male mice lived longer on average, and the longest-lived ones lived longer too. The same paper found NDGA and Protandim also helped male mice. Fish oil, a bile acid drug and metformin on its own did not help. Metformin plus rapamycin did.
Interventions Testing Program. 17-alpha-estradiol at a threefold higher dose than previously tested robustly extended both median and maximal lifespan, still only in males. The same paper reports nordihydroguaiaretic acid replicated in males at the original dose and at threefold lower and higher doses, dose-dependently and without an effect on maximal lifespan, and that Protandim extended median lifespan in males only. It also reports that neither fish oil nor ursodeoxycholic acid extended lifespan, and that metformin alone at 0.1 percent of diet did not significantly extend lifespan while metformin combined with rapamycin robustly did.
- Animal study2014Acarbose, 17-alpha-estradiol, and nordihydroguaiaretic acid extend mouse lifespan preferentially in males
In mice, this is the paper that first showed the male-leaning pattern. Acarbose, 17-alpha-estradiol and NDGA all helped males live longer, and females less or not at all. It turned the male-only question into a central one for the whole field.
The original report establishing the male-preferential pattern for all three compounds. This is the paper that made sex specificity a central question in the field rather than a footnote.
- Animal study202117-alpha-estradiol late in life extends lifespan in aging UM-HET3 male mice; nicotinamide riboside and three other drugs do not affect lifespan in either sex
In mice, it worked even when started late in life, in males. That is rare for any lifespan treatment. The same round found that nicotinamide riboside, an NAD booster people take, and three other compounds did not change lifespan in either sex.
The late-start result, which is the property that makes this compound unusual: benefit when treatment began late in life, in males. The same cohort reports that nicotinamide riboside and three other compounds did not affect lifespan in either sex, which is the relevant null for anyone taking an NAD precursor.
- Animal study2017Anti-aging drugs reduce hypothalamic inflammation in a sex-specific manner
In mice, this study asked why these drugs mostly help males. It found that the drop in brain inflammation was itself different between males and females. That is part of an answer, not the whole answer.
A mechanistic follow-up asking why these effects are sex-specific, reporting that the reduction in hypothalamic inflammation itself differs by sex. A partial answer rather than a resolution.
Common questions
Has 17-alpha-estradiol been tested in people?
Not in any study cited here. In male mice, it has made them live longer again and again, even at higher doses and even when started late in life. It does nothing for female mice, and nobody knows why.
What is the 17-alpha-estradiol dosage?
No human dose established. No published study on this page has given this compound to people and reported a result. 4 animal studies, no human study
Is 17-alpha-estradiol FDA-approved?
Not approved in the United States for any use. Some European countries sell it as a scalp treatment for pattern hair loss. That is a different use, a different way of taking it and a different dose from the lifespan studies.
Does 17-alpha-estradiol extend lifespan?
In male mice, yes, strongly and more than once. At higher doses it raised how long the longest-lived mice got, not just the typical lifespan. It also worked when started late in life. In female mice, it did nothing. There is no data in people of any kind.
Will it feminise a man?
It is not meant to. That is the point of this mirror-image form. It barely switches on the usual estrogen receptors, so it lacks the feminising effects of normal estrogen. That is also why nobody knows how it works. It is not acting like a normal estrogen.
Why does it only work in males?
Nobody knows yet, and it is the most interesting open question in this field. Guesses include that males and females break the drug down differently, die of different things, or have different hormones. A follow-up study in mice found that even the drop in brain inflammation was different between the sexes.
Should I take it?
There is nothing to take. It is not approved anywhere as a treatment for the whole body. There is no ageing data in people. The evidence is a mouse result, in one sex, and nobody knows how it works.